Assertio Holdings (ASRT) Aktienübersicht
Assertio Holdings, Inc. ist ein Pharmaunternehmen, das Patienten in den Vereinigten Staaten verschiedene Produkte zur Verfügung stellt. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 3/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 6/6 |
| Dividenden | 0/6 |
Belohnungen
Risikoanalyse
Bei unseren Risikoprüfungen wurden keine Risiken für ASRT festgestellt.
ASRT Community Fair Values
Create NarrativeSee what 29 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Assertio Holdings, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$23.32 |
| 52-Wochen-Hoch | US$23.36 |
| 52-Wochen-Tief | US$8.61 |
| Beta | 0.45 |
| 1 Monat Veränderung | 29.48% |
| 3 Monate Veränderung | 88.44% |
| 1 Jahr Veränderung | 133.50% |
| 3 Jahre Veränderung | -78.70% |
| 5 Jahre Veränderung | 5.05% |
| Veränderung seit IPO | -90.28% |
Aktuelle Nachrichten und Updates
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.Recent updates
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.
ASRT: Reverse Split And 2026 Guidance Will Shape Future Upside Potential
Analysts have kept Assertio Holdings' fair value estimate steady at $28.00, while modestly refining their assumptions around revenue growth, profit margins, and future P/E. This has led to a recalibrated price target that they see as better aligned with updated fundamentals.ASRT: Reverse Split And 2026 Guidance Will Reshape Risk Reward Profile
Analysts have raised their price target on Assertio Holdings from $1.75 to $28.00, citing updated assumptions for revenue growth, profit margins, discount rate, and a lower future P/E multiple in their models. Analyst Commentary Even with a sharply higher price target in some models, not all research views point in the same direction for Assertio Holdings.ASRT: Reverse Split And Earnings Power Will Support Rerating Potential
Analysts have raised their price target on Assertio Holdings, maintaining the figure at $37.44, while citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E as the reasons for the revised assessment. Analyst Commentary Bullish Takeaways Bullish analysts view the reaffirmed $37.44 price target as consistent with their updated fair value work, suggesting the current share price still leaves room for upside if execution tracks their assumptions.
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have revised their price target for Assertio Holdings to $45.00. The update reflects slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E expectations.Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders would be excited to see that the share price has had a great...ASRT: Reverse Split And Earnings Visibility Will Reframe Risk Reward Profile
Analysts have modestly adjusted their price target for Assertio Holdings, citing updated views on discount rates, long term revenue trends and sustainable profit margins, along with a slightly higher assumed future P/E multiple. Analyst Commentary Recent Street research on a comparable operator in the transport and infrastructure space, Asur, offers a useful reference point for how analysts are currently weighing valuation against execution risk when traffic and revenue visibility are in focus.ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have trimmed their price target on Assertio Holdings to $45.00 from $44.99, reflecting updated assumptions that indicate a smaller revenue decline, higher profit margins near 15%, and a lower future P/E closer to 16x. Analyst Commentary Bullish analysts in the wider market are pointing to companies that maintain or improve profitability targets and trade on mid-teens P/E multiples as potential opportunities for re-rating when execution holds up.ASRT: Reverse Split And New Leadership Will Reframe Risk Reward Profile
Analysts lifted their fair value estimate for Assertio Holdings from $2.69 to $37.44, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E as the key drivers of the new price target range. Analyst Commentary Recent Street research on airport operators with similar business profiles offers some context for how analysts might be thinking about Assertio Holdings, particularly around traffic trends, valuation ranges, and the balance between upside potential and execution risk.ASRT Will Rely On Cost Discipline To Support Future Upside Potential
Analysts have raised their price target on Assertio Holdings significantly, from approximately $3.00 to about $45.00. This reflects a higher assumed fair value multiple despite more conservative expectations for revenue growth and profit margins.Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Lagging The Industry But So Is The Business
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy...Is Assertio Holdings (NASDAQ:ASRT) Using Debt In A Risky Way?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Assertio Holdings, Inc. (NASDAQ:ASRT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Assertio Holdings, Inc. ( NASDAQ:ASRT ) missed earnings with its latest first-quarter results, disappointing...Is Assertio Holdings (NASDAQ:ASRT) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Rolvedon And Sympazan Will Create New Market Opportunities
Strategic market penetration and increased commercial efforts for Rolvedon and Sympazan aim to boost revenue growth.Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues Are Not Doing Enough For Some Investors
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.6x might make it look like a strong buy...Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders that were waiting for something to happen have been dealt a blow...Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have retraced a considerable 30% in the last month, reversing a fair...There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 36...Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 29...Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders are no doubt pleased to see that the share price has bounced 26...Aktionärsrenditen
| ASRT | US Pharmaceuticals | US Markt | |
|---|---|---|---|
| 7D | 3.6% | 2.0% | -0.3% |
| 1Y | 133.5% | 34.8% | 24.0% |
Rendite im Vergleich zur Industrie: ASRT übertraf die Branche US Pharmaceuticals , die im vergangenen Jahr eine Rendite von 34.8 erzielte.
Rendite vs. Markt: ASRT übertraf den Markt US, der im vergangenen Jahr eine Rendite von 24 erzielte.
Preisvolatilität
| ASRT volatility | |
|---|---|
| ASRT Average Weekly Movement | 9.2% |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: ASRT hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: ASRTDie wöchentliche Volatilität (9%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 2020 | 53 | Mark L. Reisenauer | www.assertiotx.com |
Assertio Holdings, Inc. ist ein Pharmaunternehmen, das Patienten in den Vereinigten Staaten verschiedene Produkte zur Verfügung stellt. Zu den pharmazeutischen Produkten des Unternehmens gehören INDOCIN, eine orale Lösung und Zäpfchen zur Behandlung von mittelschwerer bis schwerer rheumatoider Arthritis, einschließlich akuter Schübe der chronischen Krankheit, ankylosierender Spondylitis und Osteoarthritis sowie akuter schmerzhafter Schulter- und Gichtarthritis. Außerdem bietet es Sympazan, ein Benzodiazepin zur ergänzenden Behandlung von Krampfanfällen im Zusammenhang mit dem Lennox-Gastaut-Syndrom bei Patienten ab zwei Jahren; CAMBIA, ein nichtsteroidales Antirheumatikum (NSAID) zur Behandlung von Migräneschmerzen, Übelkeit, Photophobie und Phonophobie; SPRIX, ein NSAID für die kurzfristige Behandlung von mäßigen bis mittelstarken Schmerzen, die eine Analgesie auf Opioidniveau erfordern; und ROLVEDON, ein lang wirkender Granulozyten-Kolonie-stimulierender Faktor, der zur Verringerung der durch febrile Neutropenie verursachten Infektionshäufigkeit angezeigt ist.
Assertio Holdings, Inc.'s Grundlagenzusammenfassung
| ASRT grundlegende Statistiken | |
|---|---|
| Marktanteil | US$150.70m |
| Gewinn(TTM) | -US$35.69m |
| Umsatz(TTM) | US$102.16m |
Ist ASRT zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| ASRT Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$102.16m |
| Kosten der Einnahmen | US$30.31m |
| Bruttogewinn | US$71.85m |
| Sonstige Ausgaben | US$107.54m |
| Gewinn | -US$35.69m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -5.52 |
| Bruttomarge | 70.33% |
| Nettogewinnspanne | -34.94% |
| Schulden/Eigenkapital-Verhältnis | 51.9% |
Wie hat sich ASRT auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/17 19:42 |
| Aktienkurs zum Tagesende | 2026/05/15 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Assertio Holdings, Inc. wird von 18 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Scott Henry | Alliance Global Partners |
| null null | Argus Research Company |
| Kenneth Trbovich | Brean Capital Historical (Janney Montgomery) |